A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage.

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Researchers at the University of Oklahoma report a hormone, FGF21, may reverse fatty liver disease by signaling the brain.

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works ...

It is estimated that as many as three out of ten people globally have MASLD, previously called non-alcoholic fatty liver ...

Discover a study presented at EASL 2025 that found that timely public health policies can reduce the global burden of MASLD.

Menopause at an earlier age increases risk of fatty liver disease and metabolic disorders - ...

Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...